Echo Therapeutics Announces Dismissal of Federal Court Action Dec 21, 2016 12:54PM
Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order Dec 12, 2016 02:12PM
Echo Therapeutics, Inc. Announces Second Quarter 2016 Financial Results Aug 12, 2016 02:44PM
Echo Therapeutics Common Stock to Transition from NASDAQ to OTCQB Jul 8, 2016 04:26PM
Echo Therapeutics Begins Testing of NextGen CGM System Components Jun 29, 2016 07:50AM


Jun 22, 2016 07:50AM Echo Therapeutics Announces New Patent for its Non-Invasive Sensing Technology
Jun 13, 2016 07:51AM Echo Therapeutics (ECTE) Receives IRB Approval for New Expanded CGM System Testing Clinical Protocol
Jun 13, 2016 07:50AM Echo Therapeutics Announces Institutional Review Board (IRB) Approval of New Protocol
Jun 2, 2016 07:50AM Echo Therapeutics in Final Stage of Clinical Research Organization (CRO) Selection
May 20, 2016 11:34AM Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results
May 17, 2016 07:50AM Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
May 4, 2016 04:11PM Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes and Warrants
May 3, 2016 09:42AM Echo Therapeutics Announces Significant Progress in Key Development Milestones
Apr 28, 2016 08:49AM Echo Therapeutics Announces Conference Call to Provide an Update on Corporate Milestones
Apr 14, 2016 04:30PM Echo Therapeutics Announces Voting Results of Special Meeting of Stockholders
Mar 30, 2016 05:55PM Echo Therapeutics, Inc. Announces 2015 Financial Results
Feb 22, 2016 07:50AM Echo Therapeutics Announces New Patents for Non-Invasive Sensing Technology
Feb 8, 2016 10:40AM Echo Therapeutics Announces Conference Call and Webcast to Provide a Corporate Update
Feb 1, 2016 07:50AM Echo Therapeutics (ECTE) Enters Securities Purchase Agreement for Up to $5.1M of Conv. Notes
Feb 1, 2016 07:50AM Echo Therapeutics Announces Entry Into Definitive Agreements for the Sale of up to $5.1 Million of Convertible Notes and Warrants
Dec 28, 2015 07:50AM Echo Therapeutics Appoints Elazer Edelman, M.D., Ph.D. to Board of Directors
Nov 16, 2015 04:40PM Echo Therapeutics, Inc. Announces Third Quarter 2015 Financial Results and Provides Corporate Update
Oct 21, 2015 07:50AM Echo Therapeutics' Continuous Glucose Monitoring System to be Profiled on Worldwide Business with kathy ireland®
Oct 21, 2015 07:50AM Echo Therapeutics' Continuous Glucose Monitoring System to be Profiled on Worldwide Business with kathy ireland® - NEW DAY and TIME!
Oct 15, 2015 07:50AM Echo Therapeutics' Continuous Glucose Monitoring System to be Profiled on Worldwide Business with kathy ireland
Sep 3, 2015 07:50AM Echo Therapeutics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
Aug 14, 2015 04:20PM Echo Therapeutics, Inc. Provides Corporate Update and Announces Second Quarter 2015 Financial Results
Aug 12, 2015 10:16AM Echo Therapeutics' Non-Invasive Continuous Glucose Monitoring System Likely Designation as a Class 2 Medical Device in China
Jul 1, 2015 11:06AM Echo Therapeutics Announces New Website Launch
May 26, 2015 07:50AM Echo Therapeutics, Inc. Selected for Wearable Technology Feature on Worldwide Business with kathy ireland®
May 15, 2015 03:52PM Echo Therapeutics, Inc. Announces First Quarter 2015 Financial Results
May 13, 2015 07:50AM Echo Therapeutics, Inc. to Present at 2015 Marcum MicroCap Conference
Apr 28, 2015 07:50AM Echo Therapeutics, Inc. Announces Successful CFDA Meeting
Apr 15, 2015 03:52PM Echo Therapeutics, Inc. Announces 2014 Financial Results
Mar 30, 2015 07:50AM Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone